My NCBI | Sign In
RSS Settings
  • Search: Dobbins RL[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 24

    1.

    Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects.

    Bush MA, Matthews JE, De Boever EH, Dobbins RL, Hodge RJ, Walker SE, Holland MC, Gutierrez M, Stewart MW.

    Diabetes Obes Metab. 2009 May;11(5):498-505. Epub 2008 Feb 11.PMID: 19187286 [PubMed - in process]Related articles

    2.

    Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes.

    Matthews JE, Stewart MW, De Boever EH, Dobbins RL, Hodge RJ, Walker SE, Holland MC, Bush MA; Albiglutide Study Group.

    J Clin Endocrinol Metab. 2008 Dec;93(12):4810-7. Epub 2008 Sep 23.PMID: 18812476 [PubMed - indexed for MEDLINE]Related articles

    3.

    MRI assessment of drug-induced fluid accumulation in humans: validation of the technology.

    Zuo CS, Villafuerte RA, Henry ME, Dobbins RL, Lee C, Sung Y, Haws C, Butman M, Miller S, Manos A, Orban BS, Brown AP, Hodge R, Nunez DJ, Renshaw PF.

    Magn Reson Imaging. 2008 Jun;26(5):629-37. Epub 2008 May 7.PMID: 18420368 [PubMed - indexed for MEDLINE]Related articles

    4.

    Proton and sodium MRI assessment of fluid level in calf tissue.

    Zuo CS, Villafuerte RA, Henry ME, Butman M, Dobbins RL, He Y, Orban BS, Cayetano K, Wang L, Brown AP, Nunez DJ, Brown J, Renshaw PF.

    J Magn Reson Imaging. 2006 Jul;24(1):191-6.PMID: 16758473 [PubMed - indexed for MEDLINE]Related articles

    5.

    Increased cardiovascular risk associated with diabetes in Dallas County.

    Das SR, Vaeth PA, Stanek HG, de Lemos JA, Dobbins RL, McGuire DK.

    Am Heart J. 2006 May;151(5):1087-93.PMID: 16644340 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of glucose-insulin-potassium infusion on plasma free fatty acid concentrations in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.

    Addo TA, Keeley EC, Cigarroa JE, Lange RA, de Lemos JA, Dobbins RL, McGuire DK.

    Am J Cardiol. 2004 Nov 15;94(10):1288-9.PMID: 15541248 [PubMed - indexed for MEDLINE]Related articles

    7.

    Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

    Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL.

    Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E462-8. Epub 2004 Aug 31.PMID: 15339742 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Measuring in-vivo metabolism using nuclear magnetic resonance.

    Dobbins RL, Malloy CR.

    Curr Opin Clin Nutr Metab Care. 2003 Sep;6(5):501-9. Review.PMID: 12913667 [PubMed - indexed for MEDLINE]Related articles

    9.

    Chemical sympathectomy alters regulation of body weight during prolonged ICV leptin infusion.

    Dobbins RL, Szczepaniak LS, Zhang W, McGarry JD.

    Am J Physiol Endocrinol Metab. 2003 Apr;284(4):E778-87. Epub 2002 Dec 27.PMID: 12626326 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging.

    Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D'Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG.

    Magn Reson Med. 2003 Mar;49(3):417-23.PMID: 12594743 [PubMed - indexed for MEDLINE]Related articles

    11.

    The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats.

    Dobbins RL, Szczepaniak LS, Myhill J, Tamura Y, Uchino H, Giacca A, McGarry JD.

    Diabetes. 2002 Jun;51(6):1825-33.PMID: 12031970 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Bulk magnetic susceptibility effects on the assessment of intra- and extramyocellular lipids in vivo.

    Szczepaniak LS, Dobbins RL, Stein DT, McGarry JD.

    Magn Reson Med. 2002 Mar;47(3):607-10.PMID: 11870849 [PubMed - indexed for MEDLINE]Related articles

    13.

    Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity.

    Majdic G, Young M, Gomez-Sanchez E, Anderson P, Szczepaniak LS, Dobbins RL, McGarry JD, Parker KL.

    Endocrinology. 2002 Feb;143(2):607-14.PMID: 11796516 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats.

    Dobbins RL, Szczepaniak LS, Bentley B, Esser V, Myhill J, McGarry JD.

    Diabetes. 2001 Jan;50(1):123-30.PMID: 11147777 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo.

    Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT.

    Am J Physiol. 1999 May;276(5 Pt 1):E977-89.PMID: 10329993 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Fatty acids, lipotoxicity and insulin secretion.

    McGarry JD, Dobbins RL.

    Diabetologia. 1999 Feb;42(2):128-38. Review. No abstract available. PMID: 10064091 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Fatty acids, insulin resistance and pancreatic beta cell function]

    McGarry JD, Dobbins RL, Stein DT.

    Journ Annu Diabetol Hotel Dieu. 1998:1-10. Review. French. No abstract available. PMID: 9773605 [PubMed - indexed for MEDLINE]Related articles

    18.

    Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.

    Dobbins RL, Chester MW, Daniels MB, McGarry JD, Stein DT.

    Diabetes. 1998 Oct;47(10):1613-8.PMID: 9753300 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A fatty acid- dependent step is critically important for both glucose- and non-glucose-stimulated insulin secretion.

    Dobbins RL, Chester MW, Stevenson BE, Daniels MB, Stein DT, McGarry JD.

    J Clin Invest. 1998 Jun 1;101(11):2370-6.PMID: 9616208 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Rates of glucagon activation and deactivation of hepatic glucose production in conscious dogs.

    Dobbins RL, Davis SN, Neal D, Caumo A, Cobelli C, Cherrington AD.

    Metabolism. 1998 Feb;47(2):135-42.PMID: 9472959 [PubMed - indexed for MEDLINE]Related articles

    21.

    Counterregulation by epinephrine and glucagon during insulin-induced hypoglycemia in the conscious dog.

    Connolly CC, Ivy RE, Adkins-Marshall BA, Dobbins RL, Neal DW, Williams PE, Cherrington AD.

    Diabetes Res Clin Pract. 1996 Mar;31(1-3):45-56.PMID: 8792101 [PubMed - indexed for MEDLINE]Related articles

    22.

    Compartmental modeling of glucagon kinetics in the conscious dog.

    Dobbins RL, Davis SN, Neal DW, Cobelli C, Jaspan J, Cherrington AD.

    Metabolism. 1995 Apr;44(4):452-9.PMID: 7723667 [PubMed - indexed for MEDLINE]Related articles

    23.

    Pulsatility does not alter the response to a physiological increment in glucagon in the conscious dog.

    Dobbins RL, Davis SN, Neal DW, Cobelli C, Cherrington AD.

    Am J Physiol. 1994 Mar;266(3 Pt 1):E467-78.PMID: 8166269 [PubMed - indexed for MEDLINE]Related articles

    24.

    Role of glucagon in countering hypoglycemia induced by insulin infusion in dogs.

    Dobbins RL, Connolly CC, Neal DW, Palladino LJ, Parlow AF, Cherrington AD.

    Am J Physiol. 1991 Dec;261(6 Pt 1):E773-81.PMID: 1767838 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    1 free full-text article in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity